Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Definitive Healthcare Corp. Market Cap
Based on ratings from 0 stock analysts, the Definitive Healthcare Corp. stock price is expected to increase by 28.83% in 12 months. This is calculated by using the average 12-month stock price forecast for Definitive Healthcare Corp.. The lowest target is $4 and the highest is $8. Please note analyst price targets are not guaranteed and could be missed completely.
DH is a stock in Technology which has been forecasted to be worth $5.72 as an average. On the higher end, the forecast price is $8 USD by David Hynes from Canaccord Genuity and on the lower end DH is forecasted to be $4 by Saket Kalia from Barclays.
These are the latest 20 analyst ratings of DH.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| George Hill Deutsche Bank | Hold | $5 | Maintains | Aug 9, 2024 |
| Vikram Kesavabhotla Baird | Neutral | $5 | Maintains | Aug 7, 2024 |
| Saket Kalia Barclays | Equal-Weight | $4 | Maintains | Aug 7, 2024 |
| Ryan MacDonald Needham | Hold | Reiterates | Aug 6, 2024 | |
| Craig Hettenbach Morgan Stanley | Equal-Weight | $5 | Maintains | Aug 6, 2024 |
| Saket Kalia Barclays | Equal-Weight | $6 | Maintains | Jul 31, 2024 |
| Ryan MacDonald Needham | Hold | Reiterates | Jul 31, 2024 | |
| Anne Samuel JP Morgan | Underweight | $5 | Downgrade | Jul 31, 2024 |
| David Grossman Stifel | Buy | $7.5 | Maintains | Jul 31, 2024 |
| Vikram Kesavabhotla Baird | Neutral | $6 | Maintains | Jul 31, 2024 |
| George Hill Deutsche Bank | Hold | $7 | Maintains | May 9, 2024 |
| Saket Kalia Barclays | Equal-Weight | $7 | Maintains | May 9, 2024 |
| David Grossman Stifel | Buy | $9.5 | Maintains | May 8, 2024 |
| Craig Hettenbach Morgan Stanley | Equal-Weight | $9 | Downgrade | May 8, 2024 |
| Ryan MacDonald Needham | Hold | Reiterates | May 8, 2024 | |
| David Hynes Canaccord Genuity | Hold | $8 | Maintains | May 8, 2024 |
| Saket Kalia Barclays | Equal-Weight | $11 | Maintains | Mar 1, 2024 |
| David Hayes Canaccord Genuity | Hold | $10 | Maintains | Feb 29, 2024 |
| Ryan MacDonald Needham | Hold | Downgrade | Jan 17, 2024 | |
| David Grossman Stifel | Buy | $11 | Maintains | Jan 17, 2024 |
When did it IPO
2021
Staff Count
950
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Mr. Kevin D. Coop
Market Cap
$529.4M
In 2023, DH generated $251.4M in revenue, which was a increase of 12.92% from the previous year. This can be seen as a signal that DH's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Tue, 03 Sep 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) investors concerning the Company's possible violations of federal securities laws. On July 30, 2024, Definitive Healthcare disclosed that it took a $363.6 million goodwill impairment, and that as a result the Company was reducing its 2024 fiscal year guidance. On this news, Definitive Healthcare's stock price f.
Tue, 03 Sep 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Definitive Healthcare investments or would like to inquire about potentially pursuing claims to recover your l.
Tue, 27 Aug 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights
Thu, 29 Aug 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference.
Wed, 28 Aug 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On July 30, 2024, Definitive Healthcare disclosed that it took a $363.6 million goodwill impairment, and that as a result the Company was reducing its 20.
Mon, 19 Aug 2024
Sentiment - NEGATIVE
Source - Seeking Alpha
Summary - DH remains a hold rating due to its poor near-term outlook and recent results. 2Q24 results show decelerating growth, client count decline, and an elongated sales cycle. New CEO Kevin Coop could be a game changer, but there is no reason to invest in DH at this point.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
